Forget Crispr Therapeutics: This Gene-Editing Pick Attracts
The gene-editing field is maturing from hype to real profits. This article outlines why a broader set of players coul...
Compare 401(k) options by evaluating index funds against target date funds to see which aligns with your retirement plan and risk tolerance.
25,660 articlesThe gene-editing field is maturing from hype to real profits. This article outlines why a broader set of players coul...
A bold stand against dumbing down, Jennifer Siebel Newsom’s path shows that staying true to your credentials can boos...
A single family moment can reveal big money lessons. This article turns a pop culture moment into actionable steps fo...
When a star turns a festival stage into a PR moment, money follows — but so do lessons in budgeting and branding. Thi...
A major institutional bet lands on Birkenstock. Rice Hall James loads 466,577 shares, a roughly $19.8 million stake i...
Peter Thiel's hedge fund sold Nvidia shares and shifted into Microsoft and Apple, signaling a strategic pivot in AI b...
Morgan Stanley capped redemptions at a private income fund after a surge in withdrawals, fueling a Reddit-fueled sell...
Oakmark Select adds to discounted stocks in Q4, signaling a shift toward durable earnings as volatility persists. Nyg...
Retirement success isn’t just about investments. The real challenge is a quiet cost you may overlook: healthcare and ...
Robinhood’s startup fund invests roughly $35 million across Stripe and ElevenLabs, signaling a strategic tilt toward ...
Morgan Stanley’s bitcoin ETF attracted $194 million in its first month, with no net daily outflows, signaling growing...
As Treasury yields rise in 2026, CDL’s $2.29 annual dividend delivers reliable monthly cash flow from a diversified m...